Search Results - "Petto, H"

Network meta‐analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method by Mrowietz, U., Warren, R.B., Leonardi, C.L., Saure, D., Petto, H., Hartz, S., Dossenbach, M., Reich, K.

“…Background In practice, the goal of treatment for patients with psoriasis is to achieve almost clear or clear skin and maintain disease control, regardless of…”
Get full text

Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy by Hofstetter, B., Gamsjaeger, S., Varga, F., Dobnig, H., Stepan, J. J., Petto, H., Pavo, I., Klaushofer, K., Paschalis, E. P.

“…Summary The results of the present study, involving analysis of biopsies from patients who received teriparatide for 2 years and were previously either…”
Get full text

Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy? by Marchettini, P., Wilhelm, S., Petto, H., Tesfaye, S., Tölle, T., Bouhassira, D., Freynhagen, R., Cruccu, G., Lledó, A., Choy, E., Kosek, E., Micó, J.A., Späth, M., Skljarevski, V., Lenox-Smith, A., Perrot, S.

“…Background To investigate baseline demographics and disease characteristics as predictors of the analgesic effect of duloxetine and pregabalin on diabetic…”
Get full text

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis by Farahmand, P., Marin, F., Hawkins, F., Möricke, R., Ringe, J. D., Glüer, C.-C., Papaioannou, N., Minisola, S., Martínez, G., Nolla, J. M., Niedhart, C., Guañabens, N., Nuti, R., Martín-Mola, E., Thomasius, F., Peña, J., Graeff, C., Kapetanos, G., Petto, H., Gentzel, A., Reisinger, A., Zysset, P. K.

“…Summary Changes of the bone formation marker PINP correlated positively with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis…”
Get full text

Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis by Stepan, J. J, Burr, D. B, Li, J, Ma, Y. L, Petto, H, Sipos, A, Dobnig, H, Fahrleitner-Pammer, A, Michalská, D, Pavo, I

“…Summary The level of increased bone formation after 24 months of treatment with teriparatide (rhPTH (1-34), TPTD) is similar in patients who were either…”
Get full text

The Lumley-Method, A Recommended Network Meta-Analysis for Indirect Comparisons, Summarized for Practitioners by Petto, H, Kadziola, Z, Belger, M.A

Get full text

Inclusion Of Multiple Studies In Matching Adjusted Indirect Comparisons (Maic) by Belger, M, Brnabic, A, Kadziola, Z, Petto, H, Faries, D

Get full text

Alternative Weighting Approaches For Matching Adjusted Indirect Comparisons (Maic) by Belger, M, Brnabic, A, Kadziola, Z, Petto, H, Faries, D

Get full text

Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS) by Ljunggren, Ö., Benhamou, C. L., Dekker, J., Kapetanos, G., Kocjan, T., Langdahl, B. L., Napoli, N., Petto, H., Nikoli, T., Lindh, E.

“…Abstract Objective: To better characterize patients who are currently being prescribed teriparatide in Europe, this article describes the study design and…”
Get full text

High resolution CT based assessment of bone microstructure surpasses QCT and DXA in the association with spinal fracture severity in men with glucocorticoid-induced osteoporosis by Graeff, C, Marin, F, Petto, H, Glüer, C.C

Get full text

Fracture incidence and compliance to treatment in the daily clinical practice: 24-month final results of the observational Italian Study on Severe Osteoporosis (ISSO) by Massari, L, Vacca, F, Rubinacci, A, Nacci, F, Isaia, G.C, Del Fiacco, R, Petto, H, Marchi, P, Silvestri, S

Get full text

Changes in body composition after 9 months of treatment with exenatide twice daily versus glimepiride: comment letter on Jendle et al by Gallwitz, B., Haupt, A., Kraus, P., Peters, N., Petto, H., Dotta, F., Petto, H., Poll, L., Rose, L., Schernthaner, G.

Get full text

Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women by Ringe, J. D., Christodoulakos, G. E., Mellström, D., Petto, H., Nickelsen, T., Marín, F., Pavo, I.

“…ABSTRACT Objectives: The aim was to investigate patient compliance with different osteoporosis medications commonly prescribed in clinical practice, to…”
Get full text

Scalable Microwave Plasma Sources From Low to Atmospheric Pressure by Schulz, A., Büchele, P., Ramisch, E., Janzen, O., Jimenez, F., Kamm, C., Kopecki, J., Leins, M., Merli, S., Petto, H., Mendez, F.R., Schneider, J., Schumacher, U., Walker, M., Stroth, U.

“…There are very specific demands on the plasma processes used in various plasma technological applications. Microwave plasmas offer a wide range of applications…”
Get full text

Changes in serum PINP during teriparatide therapy correlate with improvements in vertebral strength as assessed by finite element modeling in men with glucocorticoid-induced osteoporosis by Farahmand, P, Marin, F, Hawkins, F, Möricke, R, Ringe, J.D, Glüer, C.C, Papaioannu, N, Minisola, S, Martínez, G, Nolla, J.M, Niedhart, C, Guañabens, N, Nuti, R, Martín-Mola, E, Thomasius, F, Kapetanos, G, Peña, J, Graeff, C, Petto, H, Gentzel, A, Reisinger, A, Zysset, P

Get full text

Teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPS trial by Glüer, C.C, Marin, F, Ringe, J.D, Hawkins, F, Möricke, R, Papaioannu, N, Farahmand, P, Minisola, S, Martínez, G, Nolla, J.M, Niedhart, C, Guañabens, N, Nuti, R, Martín-Mola, E, Thomasius, F, Kapetanos, G, Peña, J, Graeff, C, Petto, H, Sanz, B, Reisinger, A, Zysset, P

Get full text

PCR200 Measuring the Burden of Alopecia Areata With the European Quality of Life-5 Dimensions (EQ-5D): Results From a Real-World Survey in 5 European Countries by Bewley, A, Vañó Galván, S, Johansson, E, Austin, J, Durand, F, Petto, H, Maria Piraccini, B, Blume-Peytavi, U

Get full text

PRM198 - The Lumley-Method, A Recommended Network Meta-Analysis for Indirect Comparisons, Summarized for Practitioners by Petto, H., Kadziola, Z., Belger, M.A.

Get full text

Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks by Aspenberg, Per, Malouf, Jorge, Tarantino, Umberto, García-Hernández, Pedro A., Corradini, Costantino, Overgaard, Søren, Stepan, Jan J., Borris, Lars, Lespessailles, Eric, Frihagen, Frede, Papavasiliou, Kyriakos, Petto, Helmut, Caeiro, José Ramón, Marin, Fernando

“…Osteoporosis drugs might affect fracture-healing. We therefore studied the effects of teriparatide in comparison with risedronate on recovery after…”
Get full text

PRM218 - Application of Simple Imputation Techniques for Missing Pairwise Contrasts from Multi-Arm Trials when Using Frequentist Network Meta Analysis by Petto, H, Brnabic, A, Kadziola, Z, Belger, M

Get full text